ArticleJournal of experimental & clinical cancer research : CR2022

SKP2 drives the sensitivity to neddylation inhibitors and cisplatin in malignant pleural mesothelioma.

Iris Chiara Salaroglio et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.